Cortex Pharmaceuticals Inc.: The Irvine neurological drug...

Cortex Pharmaceuticals Inc.: The Irvine neurological drug company said it lost $1.6 million, or 5 cents a share, for its second quarter ended Dec. 31, compared with a net loss of $967,263, or 5 cents a share, for the corresponding period a year earlier. The company reported no revenue. For the first half, the company lost $3.1 million, or 10 cents a share, compared with $1.8 million, or 10 cents a share, for the comparable six-month period in 1993.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World
65°